PT Diagnos Laboratorium Utama Tbk (DGNS) shares got auto rejected (ARA) in its trading debut on the Indonesia Stock Exchange (IDX), today.

At the start of trading, DGNS shares soared 70 points or 35 percent to  Rp270 per share. DGNS trading was immediately halted for the session as it had touched the ARA boundary.

According to Bourse regulation, for shares with a price of Rp. 200 to Rp. 5,000, the maximum daily increase is 25 percent of the opening price. If you touch this percentage, the shares will be directly affected by ARA.

The market capitalization of the issuer engaged in the health laboratory is Rp37.5 billion.

Based on the company's prospectus, DGNS sold 250 million shares or 20 percent of the issued and fully paid-up capital through IPO. The shares are priced at Rp200 per share.

The company targets to raise Rp50 billion. PT Mirae Asset Sekuritas Indonesia acted as the underwriter for the IPO of DGNS shares.